Author： Shunkwiler Lauren Ferris Gina Kunos Charles
Publisher： MDPI
E-ISSN： 1422-0067|14|2|3773-3785
ISSN： 1422-0067
Source： International Journal of Molecular Sciences, Vol.14, Iss.2, 2013-02, pp. : 3773-3785
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Pharmacologic inhibitors of poly(ADP-ribose) polymerase (PARP) putatively enhance radiation toxicity in cancer cells. Although there is considerable information on the molecular interactions of PARP and BRCA1- and BRCA2-deficient cancers, very little is known of the PARP inhibition effect upon cancers proficient in DNA double-strand break repair after ionizing radiation or after stalled replication forks. In this work, we investigate whether PARP inhibition by ABT-888 (veliparib) augments death-provoking effects of ionizing radiation, or of the topoisomerase I poison topotecan, within uterine cervix cancers cells harboring an unfettered, overactive ribonucleotide reductase facilitating DNA double-strand break repair and contrast these findings with ovarian cancer cells whose regulation of ribonucleotide reductase is relatively intact. Cell lethality of a radiation-ABT-888 combination is radiation and drug dose dependent. Data particularly highlight an enhanced topotecan-ABT-888 cytotoxicity, and corresponds to an increased number of unrepaired DNA double-strand breaks. Overall, our findings support enhanced radiochemotherapy toxicity in cancers proficient in DNA double-strand break repair when PARP is inhibited by ABT-888.
Related content
Access to resources
Recommend
By Koo Ja-Hyun Yoon Heeseok Kim Won-Ju Cha Donghun Choi Je-Min
International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. :